Estuary Biotherapeutics, Inc.

Estuary Biotherapeutics is a biotechnology company developing genetic medicines for patients with serious kidney diseases. It is developing AAV gene therapy that adds a healthy copy of the PKD2 gene or a functional region of the PKD1 gene for ADPKD. Source

Keywords: genetic medicines kidney diseases ADPKD AAV gene therapy PKD1 PKD2 Show all 7 keywords